Tom Erkers

About me
Publications
CV
Public outreach and news

About me

We focus on exploring the biology behind blood cancers, aiming to uncover new treatment opportunities. Through functional precision medicine methods and in-depth molecular profiling, we strive to identify therapies tailored to each individual patient

Articles

Journal article: CANCER RESEARCH. 2024;84(6):706
Advancing radiotherapy strategies for high-risk rhabdomyosarcoma: Unveiling BCLxL inhibition as a potent sensitizer to radiotherapy
Park SSW; Struyf N; Erkers T; Lehmann S; Meister MT; Drost J; Holstege FC; Herold N; Ostling P; Stenman J; Kallioniemi O; Henter J-I; Seashore-Ludlow B; Karlsson K
Journal article: BLOOD CANCER DISCOVERY. 2024;5(2_Supplement):p30
Abstract P30: Therapeutic activation of pre-B-cell receptor signaling in high-risk pediatric ALL: exploiting TCF3 and MYC-linked vulnerabilities
Leo IR; Post F; Struyf N; Qi X; Aswad L; Nguyen TT; Tamai M; Akahane K; Pokrovskaja-Tamm K; Erkers T; Inukai T; Lehtiö J; Jafari R
Article: NPJ PRECISION ONCOLOGY. 2024;8(1):38
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Struyf N; Osterroos A; Vesterlund M; Arnroth C; James T; Sunandar S; Mermelekas G; Bohlin A; Hamberg Levedahl K; Bengtzen S; Jafari R; Orre LM; Lehtio J; Lehmann S; Ostling P; Kallioniemi O; Seashore-Ludlow B; Erkers T
Article: SCIENTIFIC REPORTS. 2024;14(1):4000
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia
Bwanika HC; Leo IR; Struyf N; Talanti A; Aswad L; Konnur A; Bjoerklund A-C; Heyman M; Rassidakis G; Erkers T; Seashore-Ludlow B; Jafari R; Pokrovskaja Tamm K
Journal article: BLOOD. 2023;142:5015
Computational Approach Based on Independent Drug Action Identifies Clinically Relevant Combinations for Acute Myeloid Leukemia
Xian X; Sandhu V; Eide CA; Kurtz SE; Malani D; Erkers T; Kallioniemi O; Tyner JW; Bhatt S
Journal article: CANCER RESEARCH. 2023;83(7):6612
Data-driven hallmarks of cancer as a new paradigm for precision medicine: multi-omics and functional profiling in acute myeloid leukemia
Erkers T; Struyf N; James T; Marabita F; Vesterlund M; Vu N; Arnroth C; Osterroos A; Bohlin A; Bengtzen S; Stahl M; Jafari R; Orre L; Pawitan Y; Seashore-Ludlow B; Lehtio J; Lehmann S; Ostling P; Kallioniemi O
Article: NPJ PRECISION ONCOLOGY. 2023;7(1):32
Prediction model for drug response of acute myeloid leukemia patients
Trac QT; Pawitan Y; Mou T; Erkers T; Ostling P; Bohlin A; Osterroos A; Vesterlund M; Jafari R; Siavelis I; Backvall H; Kiviluoto S; Orre LM; Rantalainen M; Lehtio J; Lehmann S; Kallioniemi O; Vu TN
Article: JOURNAL OF INTERNAL MEDICINE. 2022;292(6):925-940
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial
Jadersten M; Lilienthal I; Tsesmetzis N; Lourda M; Bengtzen S; Bohlin A; Arnroth C; Erkers T; Seashore-Ludlow B; Giraud G; Barkhordar GS; Tao S; Fogelstrand L; Saft L; Ostling P; Schinazi RF; Kim B; Schaller T; Juliusson G; Deneberg S; Lehmann S; Rassidakis GZ; Hoglund M; Henter J-I; Herold N
Journal article: HEMASPHERE. 2022;6:442-443
P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST‐LINE CYTARABINE‐BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT‐AML TRIAL
Jädersten M; Lilienthal I; Tsesmetzis N; Lourda M; Bengtzén S; Bohlin A; Arnroth C; Erkers T; Seashore‐Ludlow B; Giraud G; Barkhordar GS; Tao S; Fogelstrand L; Saft L; Östling P; Schinazi R; Kim B; Schaller T; Juliusson G; Deneberg S; Lehmann S; Rassidakis G; Höglund M; Henter J; Herold N
Article: NATURE COMMUNICATIONS. 2022;13(1):1691
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines
Leo IR; Aswad L; Stahl M; Kunold E; Post F; Erkers T; Struyf N; Mermelekas G; Joshi RN; Gracia-Villacampa E; Ostling P; Kallioniemi OP; Tamm KP; Siavelis I; Lehtio J; Vesterlund M; Jafari R
Journal article: FRONTIERS IN IMMUNOLOGY. 2022;13:960329
Immunoregulatory effects of RGMb in gut inflammation.
Pérez-Cruz M; Iliopoulou BP; Hsu K; Wu H-H; Erkers T; Swaminathan K; Tang S-W; Bader CS; Kambham N; Xie B; Dekruyff RH; Freeman GJ; Meyer E
Article: CANCER RESEARCH. 2021;81(22):5733-5744
MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia
Sanjiv K; Calderon-Montano JM; Pham TM; Erkers T; Tsuber V; Almlof I; Hoglund A; Heshmati Y; Seashore-Ludlow B; Danda AN; Gad H; Wiita E; Gokturk C; Rasti A; Friedrich S; Centio A; Estruch M; Vatsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Monch K; Garnett MJ; Ostling P; Walfridsson J; Helleday T; Berglund UW
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(5):580-588
The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia
Mou T; Pawitan Y; Stahl M; Vesterlund M; Deng W; Jafari R; Bohlin A; Osterroos A; Siavelis L; Backvall H; Erkers T; Kiviluoto S; Seashore-Ludlow B; Ostling P; Orre LM; Kallioniemi O; Lehmann S; Lehtio J; Trung NV
Article: BLOOD. 2020;135(11):814-825
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity
Erkers T; Xie BJ; Kenyon LJ; Smith B; Rieck M; Jensen KP; Ji X; Basina M; Strober S; Negrin RS; Maecker HT; Meyer EH
Article: BLOOD ADVANCES. 2019;3(21):3419-3431
Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang S-W; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
Article: JCI INSIGHT. 2017;2(20):92865
T cells expressing chimeric antigen receptor promote immune tolerance.
Pierini A; Iliopoulou BP; Peiris H; Pérez-Cruz M; Baker J; Hsu K; Gu X; Zheng P-P; Erkers T; Tang S-W; Strober W; Alvarez M; Ring A; Velardi A; Negrin RS; Kim SK; Meyer EH
Article: SCIENTIFIC REPORTS. 2017;7(1):6123
MAIT cells accumulate in placental intervillous space and display a highly cytotoxic phenotype upon bacterial stimulation
Solders M; Gorchs L; Erkers T; Lundell A-C; Nava S; Gidlof S; Tiblad E; Magalhaes I; Kaipe H
Journal article: JOURNAL OF IMMUNOLOGY. 2017;198(1_Supplement):82.20
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells
Pierini A; Iliopoulou B; Peiris H; Perez-Cruz M; Baker J; Hsu K; Strober W; Zheng PP; Erkers T; Alvarez M; Ring A; Velardi A; Negrin RS; Kim S; Meyer E
Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2017;101(3):623-632
Frontline Science: Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells
Erkers T; Solders M; Verleng L; Bergstroem C; Stikvoort A; Rane L; Nava S; Ringden O; Kaipe H
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:1861
Mucosal-associated invariant T cells Display a Poor reconstitution and altered Phenotype after allogeneic hematopoietic stem cell Transplantation
Solders M; Erkers T; Gorchs L; Poiret T; Remberger M; Magalhaes I; Kaipe H
Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1471-1482
Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Kaipe H; Carlson L-M; Erkers T; Nava S; Mollden P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringden O
Article: STEM CELLS AND DEVELOPMENT. 2015;24(2):253-263
Treatment of Severe Chronic Graft-Versus-Host Disease with Decidual Stromal Cells and Tracing with ¹¹¹Indium Radiolabeling
Erkers T; Kaipe H; Nava S; Mollden P; Gustafsson B; Axelsson R; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(9):1418-1425
Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodygplastic Syndrome
Torlen J; Ringden O; Le Rademacher J; Batiwalla M; Chen J; Erkers T; Ho V; Kebriaei P; Keever-Taylor C; Kindwall-Keller T; Lazarus HM; Laughlin MJ; Lill M; O'Brien T; Perales M-A; Rocha V; Savani BN; Szwajcer D; Valcarcel D; Eapen M
Article: ANALYST. 2013;138(21):6573-6581
Capture and separation of biomolecules using magnetic beads in a simple microfluidic channel without an external flow device.
Wang J; Morabito K; Erkers T; Tripathi A
Article: STEM CELLS AND DEVELOPMENT. 2013;22(19):2596-2605
Decidual Stromal Cells Promote Regulatory T Cells and Suppress Alloreactivity in a Cell Contact-Dependent Manner
Erkers T; Nava S; Yosef J; Ringden O; Kaipe H
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: STEM CELLS. 2013;31(3):592-601
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2012;167(3):543-555
Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro
Karlsson H; Erkers T; Nava S; Ruhm S; Westgren M; Ringden O
Show more

All other publications

Preprint: BIORXIV. 2024
Pathway activation model for personalized prediction of drug synergy
Trac QT; Huang Y; Erkers T; Östling P; Bohlin A; Österroos A; Vesterlund M; Jafari R; Siavelis I; Bäckvall H; Kiviluoto S; Orre LM; Rantalainen M; Lehtiö J; Lehmann S; Kallioniemi O; Pawitan Y; Vu TN
Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):413-436
Novel precision medicine approaches and treatment strategies in hematological malignancies
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Ostling P; Cavelier L; Fioretos T; Smedby KE
Preprint: RESEARCH SQUARE. 2023
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Erkers T; Struyf N; Arnroth C; Vesterlund M; James T; Sunandar S; Bohlin A; Hamberg-Levedahl K; Bengtzén S; Jafari R; Orre L; Lehtiö J; Lehmann S; Ostling P; Kallioniemi O; Seashore-Ludlow B
Conference publication: BLOOD. 2022;140:6290
Comparison of Data from Fresh and Frozen AML Samples for Functional Drug Testing
Struyf N; Arnroth C; Sunandar S; Bohlin A; Bengtzen S; Lehmann S; Kallioniemi O; Ostling P; Seashore-Ludlow B; Erkers T
Conference publication: BLOOD. 2022;140:6299
Data-Driven Molecular Hallmarks of Acute Myeloid Leukemia: Biological, Prognostic and Therapeutic Implications
Erkers T; Marabita F; Struyf N; Vesterlund M; James T; Arnroth C; Bohlin A; Bengtzen S; Osterroos A; Stahl M; Jafari R; Orre L; Pawitan Y; Seashore-Ludlow B; Lehtio J; Lehmann S; Ostling P; Kallioniemi O
Preprint: RESEARCH SQUARE. 2021
Multi-omics molecular phenotyping of childhood acute lymphoblastic leukemia cell lines reveals novel drug vulnerabilities
Stahl M; Aswad L; Leo I; Kunold E; Post F; Erkers T; Struyf N; Mermelekas G; Joshi R; Gracia-Villacampa E; Östling P; Kalloniemi O; Tamm KP; Siavelis I; Lehtiö J; Vesterlund M; Jafari R
Meeting abstract: BLOOD. 2019;134:4641
High-Throughput Functional Ex-Vivo Drug Testing and Multi-Omics Profiling in Patients with Acute Myeloid Leukemia
Erkers T; Seashore-Ludlow B; Struyf N; Marabita F; James T; Malani D; Vesterlund M; Stalhl M; Pawitan Y; Lehmann S; Ostling P; Lehtio J; Kallioniemi O
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):s290
A Proinflammatory Invariant Natural Killer T Cell Phenotypic State Associates with Human Graft-Versus-Host Disease Onset
Xie BJ; Erkers T; Kenyon L; Rieck M; Basina M; Jensen K; Strober S; Negrin RS; Maecker HT; Meyer EH
Meeting abstract: BLOOD. 2018;132:2111
A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response
Erkers T; Xei B; Kenyon L; Rieck M; Basina M; Jensen K; Strober S; Negrin RS; Maecker HT; Meyer EH
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):s324
Bone Morphogenetic Protein Signaling Pathway Modulation by Blocking Anti-Repulsive Guidance Molecule B Antibody Promotes Tolerance in Graft-Versus-Host Disease
Cruz MP; Hsu K; Iliopoulou BP; Erkers T; Pang W; Dekruyff RH; Freeman GJ; Meyer E
Review: STEM CELLS INTERNATIONAL. 2017;2017:5738371-17
Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy
Erkers T; Stikvoort A; Uhlin M
Meeting abstract: BLOOD. 2016;128(22):3355
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models
Pierini A; Iliopoulou B; Peiris H; Cruz MP; Baker J; Hsu K; Strober W; Zheng P-P; Erkers T; Ring A; Velardi A; Negrin RS; Kim S; Meyer E
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S48
Placenta-Derived Decidual Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustavsson B; Winiarski J; Westgren M; Sadeghi B; Mattsson J; Kaipe H
Thesis / dissertation: 2016
Immunoregulatory effects of placenta-derived decidual stromal cells
Erkers, Tom
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S149
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Ringden O; Solders M; Erkers T; Nava S; Mollden P; Khoein B; Baygan A; Aronsson-Kurttila W; Mohmand S; Remberger M; Westgren M; Mattsson J; Sadeghi B; Kaipe H
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S349-S350
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Solders M; Erkers T; Remberger M; Nava S; Mollden P; Mattsson J; Kaipe H; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S147
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Erkers T; Kaipe H; Nava S; Mollden P; Gustafsson B; Axelsson R; Ringden O
Review: BONE MARROW TRANSPLANTATION. 2014;49(6):737-743
Stromal cells-are they really useful for GVHD?
Kaipe H; Erkers T; Sadeghi B; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(2):S141-S142
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S335
A PROSPECTIVE RANDOMIZED STUDY COMPARING REDUCED-INTENSITY CONDITIONING AND MYELOABLATIVE CONDITIONING IN PATIENTS WITH MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Ringden O; Erkers T; Aschan J; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Ljungman P; Mattsson J; Remberger M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S264
STROMAL CELLS ISOLATED FROM TERM FETAL MEMBRANE GREATLY SUPPRESS ALLOANTIGEN-STIMULATED IMMUNE CELLS IN VITRO
Erkers T; Nava S; Ruhm S; Westgren M; Ringden O; Karlsson H
Conference publication: BONE MARROW TRANSPLANTATION. 2012;47:S416
A prospective randomised study comparing reduced-intensity conditioning and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Ljungman P; Mattsson J; Remberger M
Show more

Employments

Assistant Professor, Department of Oncology-Pathology, Karolinska Institutet, 2020-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2016

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI